close

AngioDynamics, Inc. designs, develops, manufactures, and markets various therapeutic and diagnostic devices that enable interventional physicians to treat peripheral vascular disease, tumors, and other non-coronary diseases. It offers various interventional product lines, such as angiographic, dialysis, vascular access, venous, thrombolytic, PTA, and drainage. The company's angiographic product line comprises angiographic catheters, entry needles, guidewires, and fluid management products. Its dialysis product line includes SCHON, EVENMORE, Centros, DURA-FLOW, SCHON XL, DYNAMIC FLOW, and CIRCLE C to treat acute renal failure, chronic renal failure, and end-stage renal disease. The company's vascular access product line consists of MORPHEUS CT PICC, micro access sets, transjugular access set, specialty access ports, Vortex line of ports, the LifeGuard safety infusion set, the LifeGuard Vision, Neostar tunneled central venous catheters, and LifeValve Platinum central venous catheter. Its venous product line includes VenaCure and Sotradecol products; thrombolytic product line comprises PULSE SPRAY, UNI FUSE, and SPEEDLYSER catheters; PTA product line consists of PTA dilation balloon catheters, including WORKHORSE and PROFILER to open blocked blood vessels and dialysis access sites; and drainage product line includes TOTAL ABSCESSION general drainage catheters. Further, the company offers various oncology product lines, including radio-frequency ablation, tumor embolization, laparoscopic resection, and NanoKnife to provide a minimally invasive approach to ablating solid cancerous or benign tumors. It offers its products to interventional radiologists, vascular surgeons, and surgical oncologists through a direct sales force in the United States and through a combination of direct sales and distributor relationships internationally. The company, formerly known as A.D., Inc., was founded in 1988 and is headquartered in Queensbury, New York.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	12.35
Volume	94134
Volume Avg	162415
52 Week High	16.60
52 Week Low	12.05
PE	48.42
PE (group average)	39
EPS Year	0.26
EPS change Q/Q	15.38%
EPS change Q/Q Yr ago	7.14%
EPS change Q/Q next Q est	50%
EPS change Y/Y	-5.88%
REV change Q/Q	2.25%
REV change Q/Q Yr ago	4.6%
EPS next Q est	0.10
EPS next Y est	0.47
Divident Annual	0.00
Dividend Yield	0%